AUROBINDO PHARMA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,103 INR | +1.78% |
|
-1.00% | +1.79% |
Chart calendar Aurobindo Pharma
fd037e696e.aRhNQ_gOUnYHPH3IXosAFf3_YeMMEb_j_dcuv5RybvE.My91F6I-Cxt9aRSSKcgyJYm5GZY1ePyisJJx06YmGYAmYH0Slk86R2t9PA~f95651fb6840678fe87df6058024cebb
Upcoming events on Aurobindo Pharma
Past events on Aurobindo Pharma
| 2024-03-13 06:15 am | Investor Meeting - Ad Factors |
| 2024-03-06 04:30 am | Investor Meeting - ICICI Securities |
| 2024-03-06 12:00 am | Investor Meeting |
| 2024-02-28 09:30 pm | JM Financial India Conference |
| 2024-02-19 | Ex-dividend day for dividende intermédiaire |
| 2024-02-15 11:30 pm | IIFL Enterprising India Global Investors Conference |
| 2024-02-14 11:30 pm | Axis Capital India Conference |
| 2024-02-13 11:30 pm | Nuvama India Conference |
| 2024-02-11 10:00 pm | Q3 2024 Earnings Call |
| 2024-02-10 07:11 am | Q3 2024 Earnings Release |
| 2023-12-21 05:30 am | Investor Meeting |
| 2023-12-12 11:30 pm | Investor Meeting |
| 2023-12-05 11:30 pm | Investor Meeting |
| 2023-11-23 10:30 pm | Investor Meeting - Citi |
| 2023-11-22 10:30 pm | Investor Meeting - Macquarie |
| 2023-11-22 05:30 am | Investor Meeting |
| 2023-11-21 07:00 am | Investor Meeting |
| 2023-11-20 10:30 pm | Macquarie Asia Healthcare Conference |
| 2023-11-19 | Ex-dividend day for dividende intermédiaire |
| 2023-11-09 10:00 pm | Q2 2024 Earnings Call |
Past dividends on Aurobindo Pharma
| 2024-02-19 | Interim Payment 1.5 INR |
| 2023-11-19 | Interim Payment 3 INR |
| 2023-02-16 | Interim Payment 3 INR |
| 2022-06-05 | Interim Payment 4.5 INR |
| 2022-02-17 | Interim Payment 1.5 INR |
| 2021-11-16 | Interim Payment 1.5 INR |
| 2021-08-26 | Interim Payment 1.5 INR |
| 2021-02-21 | Interim Payment 1.5 INR |
| 2020-11-22 | Interim Payment 1.25 INR |
| 2020-08-20 | Interim Payment 1.25 INR |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 195 636 192 635 1.56% | 230 985 227 907 1.35% | 247 746 250 864 -1.24% | 234 555 237 036 -1.05% | 248 554 247 239 0.53% | 286 936 |
|
EBITDA Million INR | Released Forecast Spread | 38 917 39 828 -2.29% | 48 246 46 555 3.63% | 53 334 53 799 -0.86% | 43 868 45 330 -3.23% | 37 070 38 043 -2.56% | 56 895 |
|
EBIT Million INR | Released Forecast Spread | 32 237 32 775 -1.64% | 38 579 36 578 5.47% | 42 780 42 744 0.08% | 33 324 33 608 -0.84% | 24 624 25 879 -4.85% | 41 114 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 30 914 31 645 -2.31% | 37 430 35 958 4.09% | 73 436 73 955 -0.7% | 33 727 36 490 -7.57% | 26 125 26 921 -2.96% | 43 826 |
|
Net income Million INR | Released Forecast Spread | 23 647 24 752 -4.46% | 28 310 26 927 5.14% | 53 349 48 413 10.2% | 26 482 26 992 -1.89% | 19 275 20 241 -4.77% | 31 546 |
|
EPS INR | Released Forecast Spread | 40,4 43,1 -6.36% | 48,3 46,0 5.07% | 91,0 79,1 15.13% | 45,2 46,1 -1.89% | 32,9 34,5 -4.67% | 53,6 |
| Announcement Date | 28/05/19 | 03/06/20 | 31/05/21 | 30/05/22 | 27/05/23 | - |
Quarterly results
| Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 60 015 61 885 -3.02% | 57 020 61 421 -7.17% | 59 419 60 377 -1.59% | 60 022 61 970 -3.14% | 58 094 58 962 -1.47% | 62 359 59 939 4.04% | 57 394 63 014 -8.92% | 64 071 61 588 4.03% | 64 730 63 365 2.15% | 68 505 66 308 3.31% | 68 555 | 74 327 | 73 303 | 77 696 |
|
EBITDA Million INR | Released Forecast Spread | 12 747 12 991 -1.88% | 12 094 13 131 -7.9% | 11 867 12 879 -7.86% | 10 163 12 381 -17.92% | 9 744 10 357 -5.92% | 9 365 10 454 -10.42% | 7 896 10 357 -23.77% | 9 538 9 816 -2.83% | 9 963 9 877 0.87% | 11 514 10 789 6.72% | 11 963 | 15 419 | 15 263 | |
|
EBIT Million INR | Released Forecast Spread | 10 087 9 985 1.02% | 9 297 10 439 -10.94% | 8 925 10 226 -12.72% | 7 172 9 120 -21.35% | 5 888 7 366 -20.07% | 6 570 8 413 -21.91% | 4 915 7 990 -38.49% | 6 324 6 670 -5.19% | 6 508 6 704 -2.92% | 8 248 7 601 8.52% | 8 567 | 12 165 | 11 190 | 11 654 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 10 609 10 412 1.89% | 10 177 11 270 -9.7% | 9 676 10 408 -7.03% | 7 938 10 233 -22.43% | 5 936 7 960 -25.43% | 6 790 8 692 -21.88% | 5 234 8 433 -37.94% | 6 801 6 955 -2.21% | 7 301 6 814 7.15% | 8 120 7 748 4.81% | 8 800 | 11 846 | 11 205 | |
|
Net income Million INR | Released Forecast Spread | 8 016 7 998 0.22% | 7 700 8 326 -7.52% | 6 970 7 904 -11.82% | 6 047 7 497 -19.33% | 5 765 6 287 -8.31% | 5 205 6 315 -17.57% | 4 095 5 844 -29.94% | 4 913 5 671 -13.37% | 5 063 5 189 -2.44% | 5 708 5 777 -1.19% | 6 061 | 8 749 | 8 219 | |
|
EPS INR | Released Forecast Spread | 13,7 13,6 0.33% | 13,1 13,8 -4.99% | 11,9 13,8 -13.9% | 10,3 13,4 -23.23% | 9,84 10,5 -6.69% | 8,88 11,4 -21.8% | 6,99 10,6 -33.84% | 8,38 8,61 -2.67% | 8,64 8,96 -3.57% | 9,74 10,3 -4.98% | 10,7 | 16,3 | 14,6 | 14,6 |
| Announcement Date | 31/05/21 | 12/08/21 | 08/11/21 | 09/02/22 | 30/05/22 | 11/08/22 | 12/11/22 | 09/02/23 | 27/05/23 | 12/08/23 | - | - | - | - |
More events
Past sector events for Aurobindo Pharma
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AUROPHARMA Stock
- Calendar Aurobindo Pharma
